CTSV and breast carcinoma: In agreement with previous results, CTSV nuclear expression was notably reduced following treatment with ivermectin in both the MCF-7 and ZR75-1 cells, suggesting that the identified NLS motif and importin-mediated trafficking are a viable mechanism for CTSV localisation to the nucleus of breast cancer cells (Figure 5D).